Literature DB >> 21269825

Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease.

Michael A Brodney1, David D Auperin, Stacey L Becker, Brian S Bronk, Tracy M Brown, Karen J Coffman, James E Finley, Carol D Hicks, Michael J Karmilowicz, Thomas A Lanz, Dane Liston, Xingrong Liu, Barbara-Anne Martin, Robert B Nelson, Charles E Nolan, Christine E Oborski, Christine P Parker, Karl E G Richter, Nikolay Pozdnyakov, Barbara G Sahagan, Joel B Schachter, Sharon A Sokolowski, Barbara Tate, Jeffrey W Van Deusen, Douglas E Wood, Kathleen M Wood.   

Abstract

The synthesis and structure-activity relationship (SAR) of a novel series of di-substituted imidazoles, derived from modification of DAPT, are described. Subsequent optimization led to identification of a highly potent series of inhibitors that contain a β-amine in the imidazole side-chain resulting in a robust in vivo reduction of plasma and brain Aβ in guinea pigs. The therapeutic index between Aβ reductions and changes in B-cell populations were studied for compound 10 h.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21269825     DOI: 10.1016/j.bmcl.2010.12.117

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  MIL-101(Cr), an Efficient Heterogeneous Catalyst for One Pot Synthesis of 2,4,5-tri Substituted Imidazoles under Solvent Free Conditions.

Authors:  Faranak Manteghi; Fatemeh Zakeri; Owen James Guy; Zari Tehrani
Journal:  Nanomaterials (Basel)       Date:  2021-03-26       Impact factor: 5.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.